148 related articles for article (PubMed ID: 27454594)
41. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
42. Bilateral pheochromocytoma as first manifestation of von Hippel-Lindau disease: a case report.
Catli G; Abaci A; Neumann HC; Altincik A; Demir K; Böber E
Turk J Pediatr; 2012; 54(5):532-5. PubMed ID: 23427520
[TBL] [Abstract][Full Text] [Related]
43.
El-Maouche D; Sadowski SM; Papadakis GZ; Guthrie L; Cottle-Delisle C; Merkel R; Millo C; Chen CC; Kebebew E; Collins MT
J Clin Endocrinol Metab; 2016 Oct; 101(10):3575-3581. PubMed ID: 27533306
[TBL] [Abstract][Full Text] [Related]
44. Breast Fibroadenoma With Increased Activity on 68Ga DOTATATE PET/CT.
Papadakis GZ; Millo C; Sadowski SM; Karantanas AH; Bagci U; Patronas NJ
Clin Nucl Med; 2017 Feb; 42(2):145-146. PubMed ID: 27879489
[TBL] [Abstract][Full Text] [Related]
45. Von Hippel-Lindau Syndrome.
Ben-Skowronek I; Kozaczuk S
Horm Res Paediatr; 2015; 84(3):145-52. PubMed ID: 26279462
[TBL] [Abstract][Full Text] [Related]
46. Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management.
Kunikowska J; Lewington V; Krolicki L
Clin Nucl Med; 2017 Dec; 42(12):905-911. PubMed ID: 29076910
[TBL] [Abstract][Full Text] [Related]
47. From arterial hypertension complications to von Hippel-Lindau syndrome diagnosis.
Kozaczuk S; Ben-Skowronek I
Ital J Pediatr; 2015 Aug; 41():56. PubMed ID: 26268347
[TBL] [Abstract][Full Text] [Related]
48. ACR Practice Parameter for the Performance of Gallium-68 DOTATATE PET/CT for Neuroendocrine Tumors.
Subramaniam RM; Bradshaw ML; Lewis K; Pinho D; Shah C; Walker RC
Clin Nucl Med; 2018 Dec; 43(12):899-908. PubMed ID: 30394933
[TBL] [Abstract][Full Text] [Related]
49. Expression of vascular endothelial growth factor in von Hippel-Lindau syndrome-associated papillary cystadenoma of the epididymis.
Leung SY; Chan AS; Wong MP; Yuen ST; Fan YW; Chung LP
Hum Pathol; 1998 Nov; 29(11):1322-4. PubMed ID: 9824115
[TBL] [Abstract][Full Text] [Related]
50. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau.
Hammel PR; Vilgrain V; Terris B; Penfornis A; Sauvanet A; Correas JM; Chauveau D; Balian A; Beigelman C; O'Toole D; Bernades P; Ruszniewski P; Richard S
Gastroenterology; 2000 Oct; 119(4):1087-95. PubMed ID: 11040195
[TBL] [Abstract][Full Text] [Related]
51. Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis.
Gilcrease MZ; Schmidt L; Zbar B; Truong L; Rutledge M; Wheeler TM
Hum Pathol; 1995 Dec; 26(12):1341-6. PubMed ID: 8522307
[TBL] [Abstract][Full Text] [Related]
52. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
53. Von Hippel-Lindau disease.
Sano T; Horiguchi H
Microsc Res Tech; 2003 Feb; 60(2):159-64. PubMed ID: 12539169
[TBL] [Abstract][Full Text] [Related]
54. CT diagnosis of unsuspected von Hippel-Lindau disease.
Kuhlman JK; Fishman EK; Marshall FF; Siegelman SS
Urology; 1987 Nov; 30(5):505-8. PubMed ID: 3672691
[TBL] [Abstract][Full Text] [Related]
55. Head-to-Head Comparison of
Johnbeck CB; Knigge U; Loft A; Berthelsen AK; Mortensen J; Oturai P; Langer SW; Elema DR; Kjaer A
J Nucl Med; 2017 Mar; 58(3):451-457. PubMed ID: 27660147
[TBL] [Abstract][Full Text] [Related]
56. [Diagnosis and treatment of pancreatic neuroendocrine neoplasmas in Von Hippel-Lindau syndrome].
Liu WK; Tian XD; Yang YM
Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):869-872. PubMed ID: 30392308
[TBL] [Abstract][Full Text] [Related]
57. von Hippel-Lindau disease: epididymal cystadenoma targeted by metastatic events.
Mehta GU; Shively SB; Gläsker S; Bechert CJ; Zhuang Z; Raffeld M; Lonser RR; Oldfield EH; Vortmeyer AO
Urology; 2007 Jun; 69(6):1209.e9-12. PubMed ID: 17572225
[TBL] [Abstract][Full Text] [Related]
58. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
Richard S; Beroud C; Joly D; Chretien Y; Benoit G
Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
[TBL] [Abstract][Full Text] [Related]
59. Increased Activity Due to Fractures Does Not Significantly Affect the Accuracy of 68Ga-DOTATATE PET/CT in the Detection of Culprit Tumor in the Evaluation of Tumor-Induced Osteomalacia.
Ding J; Hu G; Wang L; Li F; Huo L
Clin Nucl Med; 2018 Dec; 43(12):880-886. PubMed ID: 30273206
[TBL] [Abstract][Full Text] [Related]
60.
Patel M; Jha A; Antic T; Nielsen SM; Churpek JE; Ling A; Pacak K
Nucl Med Mol Imaging; 2022 Oct; 56(5):259-262. PubMed ID: 36310832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
